canagliflozin 300 MG Oral Tablet

RxCUI: 1373471
RxNorm name: canagliflozin 300 MG Oral Tablet
Display name: canagliflozin 300 MG Oral Tablet
Full name: canagliflozin 300 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
INVOKANA	CANAGLIFLOZIN	Janssen Pharmaceuticals, Inc.	b9057d3b-b104-4f09-8a61-c61ef9d4a3f3	2026-06-11	Warnings, Adverse reactions	Exact identifier rxcui: 1373471
INVOKANA	CANAGLIFLOZIN	Cardinal Health 107, LLC	5f76e16f-0c24-454a-81af-4080b312c940	2026-02-17	Warnings, Adverse reactions	Exact identifier rxcui: 1373471
INVOKANA	CANAGLIFLOZIN	A-S Medication Solutions	9679460c-55f7-4826-b55c-fe116f020358	2023-12-15	Warnings, Adverse reactions	Exact identifier rxcui: 1373471

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
b9057d3b-b104-4f09-8a61-c61ef9d4a3f3	canagliflozin 300 MG Oral Tablet	PSN	31	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20250320
b9057d3b-b104-4f09-8a61-c61ef9d4a3f3	canagliflozin 300 MG Oral Tablet	SCD	31	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20250320
5f76e16f-0c24-454a-81af-4080b312c940	canagliflozin 300 MG Oral Tablet	SCD	14	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20260217
5f76e16f-0c24-454a-81af-4080b312c940	canagliflozin 300 MG Oral Tablet	PSN	14	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20260217
9679460c-55f7-4826-b55c-fe116f020358	canagliflozin 300 MG Oral Tablet	SCD	9	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20231215
9679460c-55f7-4826-b55c-fe116f020358	canagliflozin 300 MG Oral Tablet	PSN	9	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20231215
4e946ba3-02c4-4a10-9d5e-f2d87b534dc3	canagliflozin 300 MG Oral Tablet	PSN	5	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20231024
4e946ba3-02c4-4a10-9d5e-f2d87b534dc3	canagliflozin 300 MG Oral Tablet	SCD	5	These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013	20231024